DRIO DarioHealth Corp.
USHealthcareAs of 2026-07-10 16:00
Why DRIO matters now
DarioHealth Corp. (DRIO) is a US stock in Healthcare. The latest InvestLog snapshot shows $7.22 with +3.14% on the session and $52.8M in market capitalization; recent performance reads 1-month -15.49% and YTD -39.10%.
The latest financial table shown here is Q1 2026, with revenue of $5.6M, net income of $-8.2M, and EPS of $0.17. Investors can compare that operating picture with valuation signals such as P/E 5.83 and FCF yield -50.2%.
The latest indexable market news headline is "Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $14.00; recent insider activity includes PALUMBO JOHN R filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
5.83
PEG
0.00
P/B
5.51
P/S
2.39
EV/EBITDA
-1.93
DCF Value
$-6.08
FCF Yield
-50.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
56.5%
Operating Margin
-251.9%
Net Margin
295.9%
ROE
93.2%
ROA
60.7%
ROIC
-56.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $5.6M | $-8.2M | $0.17 |
| Q4 2025 | $5.2M | $86.0M | $1.90 |
| FY 2025 | $22.4M | $-41.7M | $1.24 |
| Q3 2025 | $5.0M | $-2.1M | $0.38 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$12.50
Target (Median)
$14.00
Target Range
$7.50 - $16.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
—
Beta
1.08
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.